Modeling Endothelialized Hepatic Tumor Microtissues for Drug Screening
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Compared to various traditional 2D approaches, the scaffold‐based 3D tumor models have emerged as an effective strategy to investigate the complex mechanisms behind cancer progression and responses to drug treatments, by providing biomimetic extracellular matrix and stromal‐like microenvironments including the vascular elements. Herein, the development of a 3D endothelialized hepatic tumor microtissue model based on the fusion of multicellular aggregates of human hepatocellular carcinoma cells and human umbilical vein endothelial cells cocultured in poly(lactic‐co‐glycolic acid)‐based porous microspheres (PLGA PMs) is reported. In contrast to the conventional 2D culture, the cells within the PLGA PMs exhibit significantly higher half‐maximal inhibitory concentration values against anticancer drugs, including doxorubicin and cisplatin. Furthermore, the feasibility of coculturing other cell types, such as fibroblasts (L929) and HepG2 cells, is investigated. Together, the findings emphasize the significance of engineered 3D hepatic tumor microtissue models using PLGA PM‐based multicellular aggregates for drug screening applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Vascularized cancer on a chip: the effect of perfusion on growth and drug delivery of tumor spheroid
Nashimoto, Y., Okada, R., Hanada, S., Arima, Y., Nishiyama, K., Miura, T., & Yokokawa, R. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119547 · Cited by 332
Mechanisms of tumor cell extravasation in an in vitro microvascular network platform
Chen, M. B., Whisler, J. A., Jeon, J. S., & Kamm, R. D. (2013) · Integrative Biology · doi:10.1039/c3ib40149a · Cited by 308
Yip, D., & Cho, C. H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.008 · Cited by 236
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Bioengineered in vitro models of thrombosis: methods and techniques
Zhang, Y. S., Oklu, R., & Albadawi, H. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.08.08 · Cited by 23
Self-citation
Cited by
Choi, Y.-M., Lee, H., Ann, M., Song, M., Rheey, J., & Jang, J. (2023) · Biofabrication · doi:10.1088/1758-5090/acd95f · Cited by 94
“The complexity of the tumor microenvironment (TME) and the genetic features of patients are major factors that influence drug response [17–19], with there being few in vitro cancer models that simultaneously satisfy these conditions [20–22].”
New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay
Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202201784 · Cited by 84
Hierarchical Hydrogels with Ordered Micro-Nano Structures for Cancer-on-a-Chip Construction
Zhu, L., Shao, C., Chen, H., Chen, Z., & Zhao, Y. (2021) · Research · doi:10.34133/2021/9845679 · Cited by 41
“In addition, with the addition of CPT, the cell viability of the CPT-DOX group was lower than that of the DOX group and the CPT group under the synergistic action of drugs, which was consistent with related reports [38, 39].”
ResultVascularised organoids: Recent advances and applications in cancer research
Zhou, R., Brislinger, D., Fuchs, J., Lyons, A., Langthaler, S., Hauser, C. A. E., & Baumgartner, C. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70258 · Cited by 41
Emerging Functional Porous Scaffolds for Liver Tissue Engineering
Wang, J., Huang, D., Chen, D., Ren, H., & Zhao, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403741 · Cited by 15
Biomacromolecular hydrogel scaffolds from microfluidics for cancer therapy: A review
Hao, S., Shi, L., Li, J., Shi, J., Kuang, G., Liang, G., & Gao, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136738 · Cited by 7
Metadata
- Authors
- Wang, Y., Kankala, R. K., Zhang, J., Hao, L., Zhu, K., Wang, S., Zhang, Y. S., & Chen, A.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2020-09-21
- Volume
- 7
- Issue
- 21
- Pages
- 2002002-2002002
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W3089027390
- Cited by
- 74
- References
- 7
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.